Genetics of diverse phenotypes in Hirschsprung disease - extension of aganglionosis, heredity and medullary thyroid carcinoma

Valtter Virtanen

Research output: ThesisDoctoral ThesisCollection of Articles

Abstract

The aim of this doctoral thesis was to identify the genetic variations of Hirschsprung disease (HD) among Finnish HD patients. How the different genotypes affect different HD phenotypes, such as the extension of aganglionosis, heredity, and HD-associated medullary thyroid cancer (MTC) was also explored. The entire patient cohort consisted of 112 HD patients. Of them, 91 adult HD patients participated the screening study for thyroid cancer. The participants went through a cross-sectional study where sequencing of the coding region of the RET gene was combined with blood tests and ultrasound of the thyroid gland. If necessary, a fine needle biopsy was also performed. An additional 21 familial HD patients participated in the second stage of the study where diverse genetic analyses were performed. In the second stage of the study, the material was analyzed comprehensively using four complementary methods. Of these, capillary sequencing of RET exons and targeted sequencing of all genes known to be associated with HD was targeted to those gene loci that have shown an association with HD in previous studies. Additionally, a genome wide association study (GWAS) and whole-exome sequencing were performed to examine the whole genome. In the screening study of thyroid cancer, two cases of MTC and one case of papillary thyroid cancer were observed. Both patients with MTC had RET variants, [p.Cys611Arg] and [p.Cys620Arg], which are known to be associated with MTC. In addition, MTC-associated RET variants were observed in four patients with no clinical signs of thyroid cancer; these patients were selected for follow-up. Based on this study, the risk of MTC among HD patients is over 300 times higher than in the normal population. The sequencing of all RET exons revealed 10 rare variants that affected gene function in 16 (14%) patients. An EDNRB frameshift variant was identified in two patients from the same family using whole-exome sequencing. GWAS confirmed the strong association of the RET gene with HD. About half of the cases in our entire sample may be statistically attributed to the common non-coding RET variants. Sequencing of all genes known to be associated with HD revealed 10 variants affecting gene function in nine patients. Overall, performing extensive gene analysis revealed a coding sequence variant affecting gene function in 31 (28%) patients from whole study cohort. Screening and gene testing are important to significantly improve the diagnostics, treatment planning, and patient counseling of HD. In particular, patients with genetic defects associated with an increased risk of thyroid cancer can be identified and treated in a timely manner.
Original languageEnglish
Supervisors/Advisors
  • Pakarinen, Mikko Petteri, Supervisor
  • Perola, Markus, Supervisor, External person
Award date1 Feb 2019
Place of PublicationHelsinki
Publisher
Print ISBNs978-951-51-4831-5
Electronic ISBNs978-951-51-4832-2
Publication statusPublished - 2019
MoE publication typeG5 Doctoral dissertation (article)

Fields of Science

  • Hirschsprung Disease
  • +genetics
  • Thyroid Neoplasms
  • Thyroid Cancer, Papillary
  • Carcinoma, Medullary
  • Carcinoma, Neuroendocrine
  • Multiple Endocrine Neoplasia Type 2a
  • Thyroid Gland
  • +diagnostic imaging
  • Calcitonin
  • Proto-Oncogene Proteins c-ret
  • Receptor, Endothelin B
  • Exons
  • Genetic Predisposition to Disease
  • 3123 Gynaecology and paediatrics
  • 3126 Surgery, anesthesiology, intensive care, radiology
  • 1184 Genetics, developmental biology, physiology
  • 3111 Biomedicine

Cite this

@phdthesis{1b9e7d7d17de48029b6f560cb27e01fe,
title = "Genetics of diverse phenotypes in Hirschsprung disease - extension of aganglionosis, heredity and medullary thyroid carcinoma",
abstract = "The aim of this doctoral thesis was to identify the genetic variations of Hirschsprung disease (HD) among Finnish HD patients. How the different genotypes affect different HD phenotypes, such as the extension of aganglionosis, heredity, and HD-associated medullary thyroid cancer (MTC) was also explored. The entire patient cohort consisted of 112 HD patients. Of them, 91 adult HD patients participated the screening study for thyroid cancer. The participants went through a cross-sectional study where sequencing of the coding region of the RET gene was combined with blood tests and ultrasound of the thyroid gland. If necessary, a fine needle biopsy was also performed. An additional 21 familial HD patients participated in the second stage of the study where diverse genetic analyses were performed. In the second stage of the study, the material was analyzed comprehensively using four complementary methods. Of these, capillary sequencing of RET exons and targeted sequencing of all genes known to be associated with HD was targeted to those gene loci that have shown an association with HD in previous studies. Additionally, a genome wide association study (GWAS) and whole-exome sequencing were performed to examine the whole genome. In the screening study of thyroid cancer, two cases of MTC and one case of papillary thyroid cancer were observed. Both patients with MTC had RET variants, [p.Cys611Arg] and [p.Cys620Arg], which are known to be associated with MTC. In addition, MTC-associated RET variants were observed in four patients with no clinical signs of thyroid cancer; these patients were selected for follow-up. Based on this study, the risk of MTC among HD patients is over 300 times higher than in the normal population. The sequencing of all RET exons revealed 10 rare variants that affected gene function in 16 (14{\%}) patients. An EDNRB frameshift variant was identified in two patients from the same family using whole-exome sequencing. GWAS confirmed the strong association of the RET gene with HD. About half of the cases in our entire sample may be statistically attributed to the common non-coding RET variants. Sequencing of all genes known to be associated with HD revealed 10 variants affecting gene function in nine patients. Overall, performing extensive gene analysis revealed a coding sequence variant affecting gene function in 31 (28{\%}) patients from whole study cohort. Screening and gene testing are important to significantly improve the diagnostics, treatment planning, and patient counseling of HD. In particular, patients with genetic defects associated with an increased risk of thyroid cancer can be identified and treated in a timely manner.",
keywords = "Hirschsprung Disease, +genetics, Thyroid Neoplasms, Thyroid Cancer, Papillary, Carcinoma, Medullary, Carcinoma, Neuroendocrine, Multiple Endocrine Neoplasia Type 2a, Thyroid Gland, +diagnostic imaging, Calcitonin, Proto-Oncogene Proteins c-ret, Receptor, Endothelin B, Exons, Genetic Predisposition to Disease, 3123 Gynaecology and paediatrics, 3126 Surgery, anesthesiology, intensive care, radiology, 1184 Genetics, developmental biology, physiology, 3111 Biomedicine",
author = "Valtter Virtanen",
note = "M1 - 103 s. + liitteet",
year = "2019",
language = "English",
isbn = "978-951-51-4831-5",
publisher = "[V. Virtanen]",
address = "Finland",

}

Genetics of diverse phenotypes in Hirschsprung disease - extension of aganglionosis, heredity and medullary thyroid carcinoma. / Virtanen, Valtter.

Helsinki : [V. Virtanen], 2019. 103 p.

Research output: ThesisDoctoral ThesisCollection of Articles

TY - THES

T1 - Genetics of diverse phenotypes in Hirschsprung disease - extension of aganglionosis, heredity and medullary thyroid carcinoma

AU - Virtanen, Valtter

N1 - M1 - 103 s. + liitteet

PY - 2019

Y1 - 2019

N2 - The aim of this doctoral thesis was to identify the genetic variations of Hirschsprung disease (HD) among Finnish HD patients. How the different genotypes affect different HD phenotypes, such as the extension of aganglionosis, heredity, and HD-associated medullary thyroid cancer (MTC) was also explored. The entire patient cohort consisted of 112 HD patients. Of them, 91 adult HD patients participated the screening study for thyroid cancer. The participants went through a cross-sectional study where sequencing of the coding region of the RET gene was combined with blood tests and ultrasound of the thyroid gland. If necessary, a fine needle biopsy was also performed. An additional 21 familial HD patients participated in the second stage of the study where diverse genetic analyses were performed. In the second stage of the study, the material was analyzed comprehensively using four complementary methods. Of these, capillary sequencing of RET exons and targeted sequencing of all genes known to be associated with HD was targeted to those gene loci that have shown an association with HD in previous studies. Additionally, a genome wide association study (GWAS) and whole-exome sequencing were performed to examine the whole genome. In the screening study of thyroid cancer, two cases of MTC and one case of papillary thyroid cancer were observed. Both patients with MTC had RET variants, [p.Cys611Arg] and [p.Cys620Arg], which are known to be associated with MTC. In addition, MTC-associated RET variants were observed in four patients with no clinical signs of thyroid cancer; these patients were selected for follow-up. Based on this study, the risk of MTC among HD patients is over 300 times higher than in the normal population. The sequencing of all RET exons revealed 10 rare variants that affected gene function in 16 (14%) patients. An EDNRB frameshift variant was identified in two patients from the same family using whole-exome sequencing. GWAS confirmed the strong association of the RET gene with HD. About half of the cases in our entire sample may be statistically attributed to the common non-coding RET variants. Sequencing of all genes known to be associated with HD revealed 10 variants affecting gene function in nine patients. Overall, performing extensive gene analysis revealed a coding sequence variant affecting gene function in 31 (28%) patients from whole study cohort. Screening and gene testing are important to significantly improve the diagnostics, treatment planning, and patient counseling of HD. In particular, patients with genetic defects associated with an increased risk of thyroid cancer can be identified and treated in a timely manner.

AB - The aim of this doctoral thesis was to identify the genetic variations of Hirschsprung disease (HD) among Finnish HD patients. How the different genotypes affect different HD phenotypes, such as the extension of aganglionosis, heredity, and HD-associated medullary thyroid cancer (MTC) was also explored. The entire patient cohort consisted of 112 HD patients. Of them, 91 adult HD patients participated the screening study for thyroid cancer. The participants went through a cross-sectional study where sequencing of the coding region of the RET gene was combined with blood tests and ultrasound of the thyroid gland. If necessary, a fine needle biopsy was also performed. An additional 21 familial HD patients participated in the second stage of the study where diverse genetic analyses were performed. In the second stage of the study, the material was analyzed comprehensively using four complementary methods. Of these, capillary sequencing of RET exons and targeted sequencing of all genes known to be associated with HD was targeted to those gene loci that have shown an association with HD in previous studies. Additionally, a genome wide association study (GWAS) and whole-exome sequencing were performed to examine the whole genome. In the screening study of thyroid cancer, two cases of MTC and one case of papillary thyroid cancer were observed. Both patients with MTC had RET variants, [p.Cys611Arg] and [p.Cys620Arg], which are known to be associated with MTC. In addition, MTC-associated RET variants were observed in four patients with no clinical signs of thyroid cancer; these patients were selected for follow-up. Based on this study, the risk of MTC among HD patients is over 300 times higher than in the normal population. The sequencing of all RET exons revealed 10 rare variants that affected gene function in 16 (14%) patients. An EDNRB frameshift variant was identified in two patients from the same family using whole-exome sequencing. GWAS confirmed the strong association of the RET gene with HD. About half of the cases in our entire sample may be statistically attributed to the common non-coding RET variants. Sequencing of all genes known to be associated with HD revealed 10 variants affecting gene function in nine patients. Overall, performing extensive gene analysis revealed a coding sequence variant affecting gene function in 31 (28%) patients from whole study cohort. Screening and gene testing are important to significantly improve the diagnostics, treatment planning, and patient counseling of HD. In particular, patients with genetic defects associated with an increased risk of thyroid cancer can be identified and treated in a timely manner.

KW - Hirschsprung Disease

KW - +genetics

KW - Thyroid Neoplasms

KW - Thyroid Cancer, Papillary

KW - Carcinoma, Medullary

KW - Carcinoma, Neuroendocrine

KW - Multiple Endocrine Neoplasia Type 2a

KW - Thyroid Gland

KW - +diagnostic imaging

KW - Calcitonin

KW - Proto-Oncogene Proteins c-ret

KW - Receptor, Endothelin B

KW - Exons

KW - Genetic Predisposition to Disease

KW - 3123 Gynaecology and paediatrics

KW - 3126 Surgery, anesthesiology, intensive care, radiology

KW - 1184 Genetics, developmental biology, physiology

KW - 3111 Biomedicine

M3 - Doctoral Thesis

SN - 978-951-51-4831-5

PB - [V. Virtanen]

CY - Helsinki

ER -